FDA Approves Device for Pancreas Care - Poll - MDSpire

FDA Approves Device for Pancreas Care

In the phase 3 PANOVA-3 trial, adding Tumor Treating Fields therapy to gemcitabine and nab-paclitaxel was associated with improved overall survival and delayed pain progression in adults with locally advanced pancreatic cancer.

  • By

  • Kathryn Wighton

  • February 12, 2026

  • 3 min

Share

Original Source(s)

FDA Approves Device for Pancreas Care

  • by Kathryn Wighton

  • February 12, 2026

Related Content

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.

More Physicians Enter Politics

Viewpoint explores how more physician-candidates could reshape both public service and public trust in medicine.

GCS May Expand CTRCD Assessment

Award-winning ASE abstract highlights GCS when GLS assessment is limited by suboptimal apical windows.